Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)Assessing the Safety and Bioactivity of SG1002 in Heart Failure Patients
- First Posted Date
- 2014-10-29
- Last Posted Date
- 2015-11-26
- Lead Sponsor
- Sulfagenix Australia Pty Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT02278276
Assessing the Safety and Ability of SG1002 to Overcome Deficits in Hydrogen Sulfide in Heart Failure Patients
Not Applicable
Completed
- Conditions
- Heart Failure
- First Posted Date
- 2013-11-20
- Last Posted Date
- 2020-05-05
- Lead Sponsor
- Sulfagenix Australia Pty Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT01989208
- Locations
- 🇦🇺
Alfred Health, Melbourne, Victoria, Australia
🇦🇺Nucleus Network, Melbourne, Victoria, Australia
News
No news found